EH1_web

V O L 2 9 I S S U E 1 / 1 9 F e b / M a r 2 0 1 9 T H E E U R O P E A N F O R U M F O R T H O S E I N T H E B U S I N E S S O F M A K I N G H E A L T H C A R E W O R K5-24 ECR SPECIAL reports and more RADIOLOGY • Artificial intelligence: • Mass Spec detects illicit drug presence LAB & DIGITAL PATHOLOGY 25-28 the time has come • Man and machine: today's centaur • Mapping the inflammatory landscape • AI for digital pathology • Radiomics on tap in 5-10 years The end of medicine as we know it The physician is no longer the lone master of diagnosis Physician, chemist and pharmacist Professor Harald Schmidt chairs the Department of Pharmacology and Personalised Medicine, at the Faculty for Health, Medicine and Life Sciences, University of Maastricht. As advanced investigator of the European Research Council (ERC) he also leads various research programmes, among them a Proof-of-Concept study on strokes; the COST Action OpenMultiMed on system medicine and the Horizon 2020 programme REPO-TRIAL. Schmidt was co-founder and managing director of Vasopharm GmbH, is co-publisher of the journal Systems Medicine and has written more than 200 refereed international publications, summary articles and books. Announcement: Professor Harald Schmidt (Maastricht) will discuss'The end of medicine as we know it' at the ETIM 2019 - Artificial Intelligence and Smart Hospital Summit Saturday 23 February 2019. Time: 3:55-4:30 pm puter does not administer therapy; AI proposes a diagnosis with a probability of x and the therapy appropriate to it.